Fact Source: Financial Supervisory Service DART
💡 3-Second Summary
ALTEOGEN decided to temporarily postpone applying for a preliminary review to move its listing from KOSDAQ to KOSPI, maintaining its KOSDAQ listing for now in consideration of recent capital market conditions and government policies.
📊 [Key Disclosure Details & Major Figures Summary]
- Reason for Submission: Temporary postponement of transferring to the KOSPI market
- Key Details:
- Background: Approved conditional KOSDAQ delisting and KOSPI transfer at the Extraordinary General Meeting of Shareholders on December 8, 2025
- Reason for Postponement: Comprehensive review of recent changes in capital market environments and government/KRX KOSDAQ activation policies
- Current Status: Application for KOSPI transfer preliminary review temporarily put on hold; maintaining KOSDAQ listing
- Future Plans: Not a total withdrawal; the company plans to review the timing and resumption of the transfer procedure in the future considering corporate value and shareholder interests (To disclose once specific details are finalized)
- Decision Date: July 16, 2026
📝 Editor’s Comment (Key Follow-up Checkpoint)
📌 Verification of Potential Resumption of Relisting Procedures and Subsequent Filings
This disclosure formally announces the temporary postponement of the preliminary review application for transferring to KOSPI while maintaining the current KOSDAQ listing. Monitoring whether the company resumes the relisting procedures and tracking related schedule updates in the future is essential because it allows investors to stay informed regarding potential market listing transfers and major corporate governance decisions. Detailed updates can be cross-checked in subsequent disclosure filings and periodic reports (Quarterly, Half-Yearly, and Annual Reports).
📢 Disclaimer & Source Notice
Source: This content has been structured and newly created based on official filing data from the Financial Supervisory Service (DART).
Investment Risk Notice: This content is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell any specific stock. All investment decisions and financial responsibilities rest entirely with the investor.
Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.
